Frequently Asked Questions

Diagnosis typically starts with a neurological exam testing reflexes, sensation, and muscle strength. Key tests include nerve conduction studies (NCS) measuring electrical signal speed, electromyography (EMG) assessing muscle electrical activity, and blood tests checking for diabetes, vitamin deficiencies, thyroid function, and autoimmune markers. A skin punch biopsy may be needed for small fiber neuropathy.

During a nerve conduction study (NCS), small electrodes are placed on the skin along a nerve pathway. Brief electrical pulses are sent through the nerve, and the speed and strength of the signal are measured. The test takes 30-60 minutes and can be mildly uncomfortable but is not generally painful. Results show whether nerves are conducting signals normally and help identify the type and location of nerve damage.

Blood tests cannot directly detect nerve damage, but they can identify many underlying causes. Common blood tests include fasting glucose and HbA1c (diabetes), vitamin B12 and folate levels, thyroid function, kidney function, liver function, complete blood count, inflammatory markers (ESR, CRP), and specific antibody tests for autoimmune conditions. A comprehensive metabolic panel is usually part of the initial workup.

A skin punch biopsy is a simple procedure where a small circular piece of skin (3mm) is removed, usually from the ankle and thigh. The sample is analyzed under a microscope to count the density of small nerve fibers (intraepidermal nerve fiber density, or IENFD). This test is the gold standard for diagnosing small fiber neuropathy, which standard nerve conduction studies often miss.

Start with your primary care doctor, who can order initial blood tests and perform a basic neurological exam. If the cause is straightforward (e.g., diabetes with typical symptoms), your PCP may manage treatment. Referral to a neurologist is recommended when the cause is unclear, symptoms are atypical or progressing rapidly, you need electrophysiology testing (EMG/NCS), or first-line treatments have failed. A neuromuscular specialist is ideal for complex cases like CIDP, vasculitic neuropathy, or hereditary conditions.

The average patient sees three or more doctors over two years before receiving a confirmed neuropathy diagnosis. A straightforward case (diabetic patient with classic stocking-glove symptoms) may be diagnosed in a single visit. Complex cases requiring specialized testing, genetic analysis, or nerve biopsy can take months. The diagnostic timeline depends on the underlying cause, which tests are needed, and specialist availability. Keeping a symptom diary and bringing organized medical records to appointments can accelerate the process.

Peripheral neuropathy is damage to the nerves outside the brain and spinal cord (the peripheral nerves). It most commonly affects the hands and feet, causing symptoms like tingling, numbness, burning pain, and muscle weakness. Over 20 million Americans are affected, though the actual number may be higher since many cases go undiagnosed.

The most common cause is diabetes, accounting for about 30% of cases. Other causes include autoimmune diseases (lupus, rheumatoid arthritis, Guillain-Barre syndrome), infections (shingles, HIV, Lyme disease), chemotherapy drugs, alcohol abuse, vitamin deficiencies (especially B12), kidney disease, and physical trauma. In 25-46% of cases, no cause is identified (idiopathic neuropathy).

It depends on the cause. Some forms are reversible if the underlying condition is treated. For example, neuropathy caused by vitamin B12 deficiency often improves with supplementation. Diabetic neuropathy can stabilize with good blood sugar control. However, many forms of neuropathy involve permanent nerve damage. Treatment then focuses on slowing progression, managing pain, and maintaining function.

Peripheral neuropathy affects an estimated 20 million or more Americans. The prevalence increases with age: about 2.4% of people overall, rising to 8% in those over 55. Among people with diabetes, up to 50% develop some form of neuropathy during their lifetime. The annual cost burden in the US exceeds $45.9 billion.

Neuropathy refers to nerve damage or dysfunction, while neuralgia specifically describes pain along a nerve pathway. All neuralgia involves neuropathy, but not all neuropathy causes pain. Some neuropathy presents primarily as numbness, weakness, or autonomic dysfunction without significant pain. Trigeminal neuralgia (sharp facial pain) and postherpetic neuralgia (pain after shingles) are common examples of pain-dominant nerve conditions.

Yes, though it is less common than in adults. Hereditary neuropathies like Charcot-Marie-Tooth disease (CMT) often present in childhood or adolescence, affecting approximately 1 in 2,500 people. Children can also develop neuropathy from type 1 diabetes, chemotherapy, Guillain-Barre syndrome, or vitamin deficiencies. Pediatric neuropathy requires evaluation by a pediatric neurologist, as the diagnostic approach and treatment options differ from adult care.

Check your feet daily for cuts, blisters, redness, or sores you may not feel. Wash feet daily in lukewarm (not hot) water and dry thoroughly between toes. Wear well-fitting shoes and never go barefoot. Trim toenails straight across. Avoid heating pads and hot water bottles on numb feet. See a podiatrist regularly. People with diabetic neuropathy should have a comprehensive foot exam at least annually.

Yes, neuropathy commonly disrupts sleep. Pain and discomfort often worsen at night when there are fewer distractions. Strategies that may help: keep a consistent sleep schedule, use a bed cradle or frame to keep blankets off sensitive feet, try cooling or warming socks based on what relieves your symptoms, consider a pain management plan timed to cover nighttime hours, and discuss sleep-specific concerns with your neurologist.

Moderate exercise typically improves neuropathy symptoms rather than worsening them. Walking, swimming, cycling, and balance exercises are generally well-tolerated. However, high-impact activities or exercises that risk foot injury should be approached carefully if you have numbness. Start slowly, wear proper footwear, check feet after exercise for unnoticed injuries, and work with a physical therapist who understands neuropathy.

Chronic neuropathy pain is strongly linked to depression, anxiety, and reduced quality of life. Studies show 30-50% of people with chronic neuropathic pain experience depression. The relationship goes both ways: depression can amplify pain perception. Treatment should address both physical and emotional well-being. Cognitive behavioral therapy, support groups, mindfulness practices, and sometimes antidepressants (which can also treat nerve pain) may help.

Diet plays a significant role, especially for diabetic neuropathy where blood sugar control directly affects nerve health. An anti-inflammatory diet rich in B vitamins, omega-3 fatty acids, and antioxidants supports nerve function. Key nutrients include B12 (found in meat, fish, dairy), B6 (poultry, potatoes, bananas, but excess B6 above 200mg/day can paradoxically cause neuropathy), alpha-lipoic acid (600mg/day has shown benefit in clinical trials), and acetyl-L-carnitine. Limit alcohol, which is directly neurotoxic.

Neuropathy can qualify as a disability under the Social Security Administration if it significantly limits your ability to work. The SSA evaluates neuropathy under listing 11.14 (peripheral neuropathy). You must demonstrate marked limitation in physical functioning despite treatment. Veterans with service-connected neuropathy may qualify for VA disability ratings ranging from 10% to 80% depending on severity. Documentation from your neurologist including EMG/NCS results, functional assessments, and treatment history strengthens disability claims.

People describe neuropathy in many ways: tingling or pins-and-needles sensations, burning or freezing pain, sharp stabbing or electric shock feelings, extreme sensitivity to touch, numbness or loss of feeling, and a sensation of wearing invisible gloves or socks. Symptoms typically start in the feet and move upward. The experience varies widely from mild tingling to severe, disabling pain.

See a doctor if tingling or numbness persists for more than a few days, spreads to other areas, appears in both feet or both hands, follows an injury, or is accompanied by weakness or muscle wasting. Seek emergency care if numbness begins suddenly, affects one entire side of the body, follows a head injury, or is accompanied by confusion, difficulty speaking, or severe headache (these could indicate stroke).

In many cases, yes, especially if the underlying cause is not addressed. Diabetic neuropathy tends to progress if blood sugar remains poorly controlled. However, the rate of progression varies enormously. Some people have mild tingling that stays stable for years. Others experience rapid worsening over months. Early diagnosis and treating the root cause offer the best chance of slowing or stopping progression.

The stocking-glove pattern describes how peripheral neuropathy symptoms typically spread: they start in the toes and feet (like wearing stockings) and gradually move upward. When symptoms reach the mid-calf level, the fingertips and hands often start showing symptoms too (like wearing gloves). This pattern occurs because the longest nerves are damaged first.

Several factors contribute to nighttime symptom flares. With fewer daytime distractions, the brain focuses more on pain signals. Body temperature drops slightly at night, which can increase nerve sensitivity. Lying flat changes blood flow patterns, and blankets pressing on sensitive feet can trigger pain. Cortisol levels, which naturally suppress inflammation, are lowest between midnight and 4 AM. Timing medication to provide peak coverage during these hours, using a bed cradle, and keeping a consistent sleep schedule can help.

Allodynia is pain caused by stimuli that normally would not be painful, such as light touch, clothing against skin, or a gentle breeze. In neuropathy, damaged nerve fibers send amplified or distorted signals to the brain, interpreting harmless contact as painful. It is especially common in small fiber neuropathy and postherpetic neuralgia. Treatment options include topical lidocaine patches applied directly to the affected area, gabapentin, pregabalin, and desensitization therapy with a pain specialist.

First-line medications include anticonvulsants (gabapentin, pregabalin), antidepressants (duloxetine, amitriptyline, nortriptyline), and topical treatments (lidocaine patches, capsaicin cream). Pregabalin (Lyrica) is FDA-approved specifically for diabetic neuropathy and postherpetic neuralgia. Gabapentin is widely used off-label. Opioids are generally avoided due to limited long-term benefit and significant risks.

Yes. Physical therapy can improve balance, strength, and mobility. Specific benefits include fall prevention training, gait improvement, strengthening exercises for weakened muscles, desensitization techniques for painful areas, and cardiovascular exercise that may improve nerve blood supply. Studies show regular exercise can slow progression and even promote nerve regeneration in some patients.

Several promising approaches are in development. Sangamo Therapeutics is running clinical trials on ST-503, a gene therapy targeting Nav1.7 sodium channels for small fiber neuropathy (FDA IND cleared 2025). Scrambler therapy, an FDA-cleared neuromodulation device, has shown 58% pain reduction in diabetic neuropathy studies. Researchers are also exploring nerve growth factor therapies, stem cell treatments, and targeted biologics.

Some types of nerve damage can be reversed, particularly when caught early and the cause is eliminated. Nerves regenerate slowly, about 1 inch per month. Neuropathy from vitamin deficiencies, alcohol, or certain medications may improve after the cause is addressed. Diabetic neuropathy can stabilize or improve with strict glucose control. However, in many cases, the goal shifts to preventing further damage rather than full recovery.

Both are first-line treatments with similar mechanisms (alpha-2-delta ligands that reduce calcium channel activity). Pregabalin has more predictable absorption and dosing (twice daily vs three times daily for gabapentin) and is FDA-approved for diabetic neuropathy. Gabapentin is available as a generic, making it significantly cheaper. Head-to-head studies show similar efficacy. Most neurologists start with gabapentin due to cost, then switch to pregabalin if side effects or scheduling are problematic. Both can cause dizziness, sedation, and weight gain.

Scrambler therapy (also called Calmare therapy) is an FDA-cleared neuromodulation device that sends electrical signals through surface electrodes to replace pain signals with non-pain information. A typical course is 10 daily 45-minute sessions. Clinical studies have shown average pain reductions of 50-80% in patients with chemotherapy-induced neuropathy and diabetic neuropathy. It is non-invasive with minimal side effects. Availability is limited to specialized pain centers, and insurance coverage varies.

Peripheral neuropathy affects sensory and motor nerves, typically in the hands and feet (stocking-glove pattern). Autonomic neuropathy damages the nerves controlling involuntary functions like heart rate, digestion, and blood pressure. Focal neuropathy affects a single nerve, often suddenly, causing weakness in specific areas like carpal tunnel syndrome or Bell's palsy.

Small fiber neuropathy (SFN) damages the thin nerve fibers that detect pain and temperature. Symptoms include burning pain, electric shock sensations, and heightened sensitivity. Standard nerve conduction studies may appear normal because they test large fibers. Diagnosis requires a skin punch biopsy to measure nerve fiber density. SFN is increasingly recognized as a distinct condition with its own treatment approaches.

CIPN is nerve damage caused by certain chemotherapy drugs, including platinum agents (cisplatin, oxaliplatin), taxanes (paclitaxel, docetaxel), and vinca alkaloids (vincristine). It affects 30-70% of patients receiving these drugs. Symptoms may appear during treatment or months afterward. Duloxetine is the only medication with strong evidence for treating established CIPN, according to ASCO guidelines.

Yes. Focal neuropathies affect individual nerves and can be one-sided. Examples include carpal tunnel syndrome (median nerve), ulnar neuropathy (elbow), and radiculopathy (nerve root compression). Proximal neuropathy, also called diabetic amyotrophy, typically starts on one side of the thigh, hip, or buttock before sometimes spreading to the other side.

Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy, affecting approximately 1 in 2,500 people worldwide. It causes progressive muscle weakness and sensory loss, primarily in the feet, legs, hands, and forearms. CMT is caused by gene mutations that damage the myelin sheath or the nerve axon itself. There are over 100 identified gene mutations across multiple CMT subtypes. While there is no cure, physical therapy, bracing, and surgery can help manage symptoms.

Guillain-Barre syndrome (GBS) is an acute autoimmune neuropathy where the immune system attacks peripheral nerves, often triggered by an infection. Symptoms typically start as tingling and weakness in the legs that spreads upward over days to weeks. About 30% of patients require mechanical ventilation due to respiratory muscle weakness. Treatment includes plasma exchange or intravenous immunoglobulin (IVIG). Most patients recover, though up to 20% have lasting disability and 3-5% die from complications.